The myriad developmental roles served by the T-box family of transcription factor genes defy easy categorization. Present in all metazoans, the T-box genes are involved in early embryonic cell fate decisions, regulation of the development of extraembryonic structures, embryonic patterning, and many aspects of organogenesis. They are unusual in displaying dosage sensitivity in most instances. In humans, mutations in T-box genes are responsible for developmental dysmorphic syndromes, and several T-box genes have been implicated in neoplastic processes. T-box transcription factors function in many different signaling pathways, notably bone morphogenetic protein and fibroblast growth factor pathways. 
INTRODUCTION
The T-box family, defined by a common DNA binding domain known as the T-box, is evolutionarily ancient, probably arising in the common ancestor of metazoan organisms (2) (Figure 1) . T-box genes first came to the attention of geneticists in 1927 with the discovery of a mutation, Brachyury (or T, for shorttail), which caused truncated tails in mice (30). In recent years, both spontaneous and induced mutations in T-box genes have demonstrated that these genes are important regulators of a wide range of tissues and organs during development, as well as major contributors to several human syndromes ( Table 1) . As this family was discovered quite recently, comparatively little is known about transcriptional regulatory capabilities and signaling interactions of its members. Nonetheless, its importance in an array of developing tissues has led to the rapid expansion of the field. In this review, we explore recent literature on T-box gene function, concentrating on mammalian development.
T-BOX TRANSCRIPTION FACTORS T-Box Proteins and DNA Binding
The T-box DNA binding sequence, the Tsite or T-box binding element (TBE), was first defined as the sequence with the highest affinity for Brachyury (57). Brachyury binds this palindromic sequence as a dimer (77) , with each monomer of Brachyury binding half of the sequence, or T-half site (5 -AGGTGTGAAATT-3 ). Extensive studies have demonstrated that all T-box proteins tested are capable of binding the T-half site as monomers (15, 49, 61, 77, 78, 97, 98) , although some have different optimal target sequences (36, 65) . Comparisons between Tbox proteins have shown preference for different synthetic combinations of T-half sites in varying orientations, numbers, and spacing (27, 97), which may help create promoter specificity for target genes.
The crystal structures of both Brachyury and TBX3 T-domain homodimers bound to the canonical T-site have been elucidated (26, 71) . Both T-box proteins make the same DNA contacts with the same amino acids, indicating strong conservation of the underlying DNA binding functions between T-box subfamilies. However, whereas the Brachyury dimer is stabilized by a hydrophobic patch and a salt bridge, TBX3 dimers are oriented differently on the DNA and are weakly connected. These differences in ternary structure probably underlie the differences in half site preference among different T-box family members.
Transcriptional Regulation
As well as binding DNA, T-box genes have been shown to regulate transcription. Activation domains have been mapped to the Schematic phylogenetic tree of the T-box gene family of vertebrates, based on the phylogenetic analysis in Reference (76) showing the relationship of genes in the five subfamilies indicated by brackets on the right. All of these genes are present in mammals with the exception of the zebrafish genes Drtbx6 and Drtbx16, which do not have orthologs in mammals.
C-terminal domains of several T-box proteins (56, 98, 120) . In some cases, the mechanism of activation is known: Tbx19 activates transcription by recruiting SRC/p160 coactivators to the promoter (68) , while Tbr1 forms a complex with nucleosome assembly proteins (112) . T-box proteins can also repress transcription, as has been shown for Tbx2 and Tbx3 (21, 41, 65) . Some T-box genes contain both activation and repression domains in their C-terminal domains (56, 98) and Tbx2 has been reported to act in either fashion, depending on promoter context (78) .
Interactions with Other Transcription Factors
Athough some T-box gene targets appear to be regulated by T-box proteins alone (60) , there is a growing body of work demonstrating that target genes are controlled in combination with other transcription factors. Cooperative binding of promoters and synergistic upregulation of target gene expression is seen with T-box factors and homeodomain (13, 61, 98) , GATA zinc finger (31, 35, 98) , and LIM domain proteins (59) . Frequently, these interactions enhance target gene activation, and Figure 1 (see text for additional references).
probably contribute to promoter specificity. Some of these interactions can be generalized to transcription factor subfamilies-both T subfamily (but not Tbx1 subfamily) proteins directly interact with all members of the Pitx family (but not the closely related Otx family) of homeodomain proteins (61) . Some of these interactions are exquisitely specific-Tbx20 interacts with GATA5 but not the related transcription factor GATA4 (98) . In an even more extreme case of specificity, LMP4 binds both of the most closely related vertebrate T-box proteins, Tbx4 and Tbx5, but interacts with each via a different LIM domain repeat (59) . The observed in vitro interactions have biological relevance. Mutations in TBX5 cause Holt-Oram syndrome (HOS), which results in multiple heart defects. While some patients have truncation mutations in TBX5 that result in loss of DNA binding or activation, others have only point mutations. Analyses of such mutant proteins have shown that loss of interaction with cardiac transcription factor NKX2-5 is sufficient to cause disease, even when the mutant TBX5 is otherwise intact (31). Likewise, point mutations in NKX2-5, which ablate TBX5 binding, have been shown to cause heart disease in humans (35), further demonstrating the biological requirements for cooperative binding between T-box proteins and other factors.
Predicting T-Box Gene Function
Reliable prediction of T-box gene function is complicated by considerable functional lability. Depending on context, T-box proteins may homodimerize, heterodimerize, or cooperatively bind other transcription factors. Individual T-box proteins can exhibit either activation or repression activities, and single genes may do both depending on promoter context. In some cases, one T-box protein is capable of competing off another at a particular promoter (40, 41), making it difficult to predict which is relevant to a particular target gene in cells where the T-box genes are coexpressed.
Several labs have attempted to inhibit individual T-box gene function with putative dominant negative proteins, e.g., a truncated version containing only the T-box domain (29, 87, 90, 101, 106a) . The action of these engineered proteins may be complex and may influence other T-box genes or targets, so caution must be used when interpreting such experiments. Although dominant negative proteins may be specific, in some cases a presumed dominant negative protein produces phenotypic consequences more severe (93) or 
T-BOX GENES DURING EARLY DEVELOPMENT
T-box gene expression is widespread during embryonic development and has been noted in all stages, from the oocyte (12, 115) to the adult (102) . In the early embryo, T-box genes are required for both evolutionarily ancient processes, such as gastrulation [recently reviewed by (94) ] and comparatively recent developments such as uterine implantation and umbilicus formation.
Roles in Extraembryonic Tissues
The earliest demonstrated role of T-box genes in mammalian embryos is that of Eomesodermin. In the mouse embryo, the first lineage decision occurs when the outer cells of the morula differentiate into the trophectoderm (TE), which will form placental structures. TE dramatically upregulates Eomesodermin. In the absence of Eomesodermin, TE cells are defective and neither proliferate in vitro nor participate in uterine implantation in vivo (89) , resulting in embryonic death shortly after implantation.
Brachyury is expressed in the caudal primitive streak and is responsible for posterior mesodermal development. Brachyury expression extends into the base of the allantois, an extraembryonic mesodermal outgrowth that will eventually become the umbilical cord. Deletion of Brachyury leads to stunted growth of the allantois; however, this is likely secondary to a more general defect in mesoderm production (8) . In contrast, Tbx4 is expressed in the allantois and has allantoisspecific effects when mutated. Specifically, Tbx4 is expressed at the site of origin of the allantois and continues to be expressed in the allantois and umbilical cord through at least 13.5 days post coitus (dpc). Embryos homozygous for a null mutation in Tbx4 have multiple abnormalities in the allantois, including upregulated apoptosis, failure to undergo characteristic morphological changes, and failure to express known markers of allantois differentiation such as Tbx2 and VCAM1. Loss of Tbx4 also disrupts allantoic vasculogenesis after endothelial cells differentiate from the allantoic mesoderm, but before they coalesce into patent blood vessels (72) . Little is known about the growth or patterning of the allantois, so it is difficult to firmly tie the diverse defects into known signaling pathways. Mutation of the bone morphogenetic protein (BMP) Bmp4 in the epiblast causes similar allantois defects (33), but Bmp4 is expressed normally in Tbx4 mutants, suggesting that Tbx4 may be a downstream effector of BMP signaling in this tissue.
Tbx3 is expressed in the yolk sac in both endoderm and mesoderm layers. Disruption of Tbx3 results in an aberrant yolk sac with variably diminished vascular development and a highly apoptotic endoderm layer (28). It is unclear whether the primary defect is in one or both layers and it is possible that these defects are secondary to heart defects in the embryo (Z.H., R.G.K., V.E.P., unpublished).
T-Box Gene Function in Mesoderm
Many T-box genes serve important functions during mesoderm formation and patterning in the vertebrate gastrula: T and Eomesodermin in the mouse; Xbra, Xeomesodermin, and XvegT in Xenopus; no tail, spadetail, eomesodermin, and tbx6 in zebrafish (75). These genes are critical for mesoderm formation at various axial levels and regulate such key factors as fibroblast growth factor (FGF) signaling and cell migration. However, T-box gene functions during gastrulation are recursive and overlapping, creating a complex web of developmental roles and signaling interactions. This field has been recently reviewed (94) .
The role of T-box genes in patterning the embryonic mesoderm, however, is not restricted to gastrulation. Several T-box genes are involved in the patterning of nascent mesoderm following its ingression through the primitive streak. Tbx6 is expressed in the paraxial, presomitic mesoderm (PSM) of the mouse embryo after its exit from the primitive streak (22a). Embryos homozygous for a null mutation in Tbx6 die mid-gestation. Rostral somites are present but morphologically abnormal, indicating that Tbx6 is not absolutely required for somite formation (24). However, the posterior embryo is progressively more affected: Caudal somites are replaced with ectopic paraxial neural tubes, and the tail bud, the ongoing source of new mesoderm, is aberrantly expanded. The Tbx6 homozygous mutant phenotype lends itself to two nonexclusive interpretations. First, the presence of ectopic neural tubes in place of caudal somites suggests that Tbx6 is required to promote a mesodermal fate in posterior paraxial tissue, and that in its absence a default neural program predominates. In vivo teratoma analysis revealed a conspicuous absence of skeletal muscle in tumors derived from Tbx6 null tail bud cells, implying a potential requirement for myogenic specification or differentiation. In vitro differentiation assays, however, show the lack of an absolute requirement for Tbx6 in myogenesis (22). A second potential explanation for the Tbx6 mutant phenotype concerns the enlarged tail bud. Levels of cellular proliferation and programmed cell death are unaltered in Tbx6 null tail buds (22), suggesting that Tbx6 mutant mesoderm may fail to migrate out of the tail bud. Although this hypothesis is not incompatible with a role for Tbx6 in mesodermal specification, the formation of ectopic neural tubes might result from an insufficient supply of mesoderm to the paraxial regions as a secondary defect of deficient migration from the tail bud.
Additional information on the role of Tbx6 comes from transgenic rescue experiments and a naturally occurring Tbx6 mutation called rib-vertebrae (rv) (113, 114) . Homozygous rv mutant embryos, as well as null Tbx6 mutant embryos rescued with a transgene that partially restores Tbx6 expression, live past mid-gestation only to display later defects in rib and vertebrae development. These abnormalities are preceded by reduced expression of markers of the anterior compartment of the somite, with reciprocally expanded expression of markers normally restricted to the posterior somite (114) , showing that Tbx6 is required to maintain the anterior compartment. Tbx6 is therefore required not only to specify somite formation in the paraxial mesoderm, but also for somite patterning. Severity of the vertebral defects increases as levels of Tbx6 are progressively reduced with rv and Tbx6 null alleles, implicating dosage as an important aspect of Tbx6 function in later somite development (113) .
Similar to Tbx6, Tbx18 is required to maintain the fate of the anterior compartment of somites. Homozygous Tbx18 null mutant mice die perinatally and display a range of rib and vertebrae defects. Molecular analysis of these mutant embryos shows that, in the absence of Tbx18, anterior and posterior somite compartment specification occurs correctly in the PSM but fails to be maintained during somite maturation (18) . Studies in zebrafish (9), chick (42a, 107), and mouse (58) show that Tbx18 is expressed in the anterior region of somites. Although the mechanism through which this expression is achieved varies between species, all studies agree that Tbx18 transcription is initiated in the PSM and progressively restricted to the anterior compartment as each somite matures. PSM injected with a Tbx18 expression vector can induce the formation of somite boundaries when grafted into PSM caudal to where Tbx18 is normally expressed, suggesting a role for the gene in somite segmentation (107) .
tbx24 in zebrafish is a third T-box gene directly involved in the regulation of vertebrate somite development. tbx24 does not cluster with any of the T-box gene subfamilies and there is no mammalian ortholog. Expression is first detected in paraxial mesoderm of the zebrafish gastrula and is later confined to the anterior and intermediate PSM. 
T-BOX GENES DURING ORGANOGENESIS Complex Functions During Cardiogenesis
Many T-box genes are expressed in specific chambers or regions of the developing vertebrate heart, including Tbx1, Tbx2, Tbx3, Tbx5, Tbx18, and Tbx20 (75). Despite overlapping expression patterns (Figure 2) , experimental studies reveal that each gene has unique developmental functions. The identification of cardiac transcriptional binding partners with differential affinities for individual T-box factors has contributed to understanding how the combined regulatory influences of multiple, related and coexpressed genes generate unique downstream target gene expression patterns during organogenesis.
Targeted mutagenesis in mouse has revealed essential roles for Tbx5, Tbx1, Tbx2, and Tbx20 in cardiac development. Mouse embryos homozygous for a null mutation in Tbx5 exhibit abnormal development of posterior heart structures, including hypoplastic left ventricle, atria, and inflow tract (IFT) (15) . These defects are accompanied by the reduced expression of critical cardiac genes, including GATA4, MLC2v, and Irx4 (15) . Ectopic expression of Tbx5 in both chick and mouse also implicates Tbx5 in the development and positioning of the interventricular septum (106) . Homozygous loss of Tbx1 produces abnormalities of anterior cardiac development, including shortening of the outflow tract (OFT), the absence of OFT septation, ventricular septal defects, and abnormal remodeling of the aortic arch arteries (52, 64, 109). Conversely, ectopic expression of Tbx1 in the heart tube can lead to an elongated OFT (50). Tbx1 mutants display reduced proliferation in the anterior heart field (AHF), which contributes to the OFT (116), demonstrating a role in proliferation of cardiac progenitor cells. Embryos homozygous for a null mutation in Tbx2 reveal a role for the gene in repressing chamber differentiation in the atrioventricular canal (AVC) during functional specialization of the ventricular and atrial compartments. Several chamber-specific markers are ectopically expressed in the AVC of Tbx2 homozygous mutants, including Nppa and Cx40 (43). In a complementary experiment, the expression of these genes is undetectable when Tbx2 is ectopically expressed throughout the heart tube (25). Many Tbx2 homozygous null mutants also exhibit defects in OFT septation and remodeling of the aortic arch arteries (43). Homozygous null Tbx20 mutants die midgestation due to defective hearts, which fail to loop and which display many morphological and molecular abnormalities, including widespread upregulation of Tbx2. The presence of two poorly developed chamber-like structures and the reduction of Nppa expression suggests that Tbx20 plays a role during cardiac chamber formation in the early heart tube (18a, 96a, 99). Together, T-box genes therefore control development of most regions of the heart and regulate multiple aspects of cardiogenesis including chamber differentiation, suppression of differentiation in nonchamber regions, and cell proliferation.
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As in the case of Tbx4 in the allantois, Tbox genes in the heart appear to be regulated by members of the BMP family. Bead implantation experiments in chick show that BMP2 can promote Tbx2 and Tbx3 expression (117) . Chick explant cultures confirm that Tbx2 and Tbx3 expression can be enhanced by the presence of BMP2, whereas Tbx2 message is reduced in the presence of the BMP inhibitor, noggin. Furthermore, cardiac Tbx2 expression is greatly reduced in homozygous Bmp2 mouse mutants (117) . In a second pathway common to several T-box genes [see (94) 50, 116) . A genetic interaction between Tbx1 and Fgf8 is also indicated by an increase in the frequency and severity of aortic arch artery remodeling defects in doubly heterozygous mutants compared to single heterozygotes (110) . Recent work suggests that T-box genes also have the capacity to regulate their own expression. T-half sites in the Tbx5 promoter were protected in fingerprinting assays after incubation with nuclear extracts, suggesting that T-box factors bind these endogenous sites. Furthermore, transfection of Tbx5 activates a Tbx5 expression reporter in cultured cell lines (100), supporting a potential auto-regulatory or T-box gene cross-regulatory loop.
The regulation of Nppa transcription during cardiac chamber formation provides an interesting example of how multiple inputs from T-box factors become integrated to generate a complex expression profile. The Nppa promoter contains Nkx binding elements (NKE) for the homeodomain factor and cardiac lineage marker Nkx2-5, in addition to several T-half sites (15, 41, 47) . Biochemical studies show that Tbx5 and Nkx2-5 not only interact with each other (47), but also specifically and cooperatively bind the Nppa promoter to synergistically activate Nppa-reporter expression (15, 47) . The success of this regulatory influence depends on intact NKEs and TBEs (15, 41) . Tbx2, a demonstrated transcriptional repressor, is also capable of cooperatively binding the Nppa promoter with Nkx2-5. Tbx5-Nkx2-5-mediated activation of the Nppa-reporter is incrementally repressed by increasing amounts of Tbx2 (41). In the 9.5 dpc mouse embryo, Tbx2 is expressed in the AVC (25, 41, 43) within a subdomain of the cardiac expression domain of Tbx5 (23) (Figure 2) . Considered together, this information has led to the hypothesis that Nppa expression is regulated by the competing interactions of Tbx5 and Tbx2 with Nkx2-5 AHF: anterior heart field AVC: atrioventricular canal
NKE:
Cardiac development, like somitogenesis, is also sensitive to the dosage of T-box gene activity. Elimination of Tbx5 leads to embryonic lethality at 9.5 dpc preceded by severe hypoplasia of posterior cardiac structures (15) . Diminished Tbx5 activity in heterozygous embryos leads to less severe cardiac abnormalities, including conduction and septal defects that contribute to compromised survival varying with genetic background. Tbx5 heterozygous mutants exhibit a reduction in Nppa expression that is intermediate between wild-type and homozygous mutant embryos (15) , demonstrating a correlation between gene dosage and target gene expression levels. Similar effects are observed in Tbx1 mutant phenotypes. Tbx1 heterozygous null mutants lack fourth arch arteries at 10.5 dpc, a defect less severe than that found in homozygous mutants (52, 64). Furthermore, combinations of null and hypomorphic mutations comprising an allelic series demonstrate differential sensitivity to Tbx1 dosage. Small reductions in Tbx1 dosage are sufficient to produce incompletely penetrant aortic arch artery defects. Progressively greater reductions in dosage increase the severity and frequency of arch artery remodeling defects and OFT septation anomalies (50). The range of developmental responses to varying
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GENE DOSAGE
The first T-box gene mutation was discovered by virtue of a phenotype affecting the tail of heterozygous newborns concomitant with the failure of homozygous mice to survive to birth, demonstrating a semidominant mode of inheritance (30). All of the known autosomal human T-box gene syndromes, with the exception of the recessive isolated ACTH deficiency, occur in heterozygous individuals, whereas homozygotes have not been identified, presumably due to embryonic lethality. In mice, heterozygous effects have been identified for half of the genes mutated, but because these defects are sometimes quite subtle, further investigations may yet identify additional examples of dosage sensitivity. Mouse studies indicate that the full spectrum of tissues affected in homozygous mutants is not necessarily affected by haploinsufficiency. In comparing human and mouse phenotypes, there is a high degree of similarity in tissues affected and the nature of the mutant defects. However, the dose sensitivity may vary considerably-leading to examples of genes that have much more severe or extensive heterozygous phenotypes in humans than that observed in mice ( Table 1) .
T-box protein levels supports the idea that dosage-sensitivity is a common theme within the T-box gene family (see sidebar).
Limb Outgrowth and Patterning
Limb development has long been a major interest of T-box gene researchers. As early as 1996 it was noted that all four members of the Tbx2 subfamily are expressed during limb development in provocative expression domains (37) (Figure 2 ). Tbx4 and Tbx5 are expressed in similar patterns but in different limbs-the hindlimbs and forelimbs, respectively. Their expression initiates in the limb fields before morphological limb buds are apparent, and is maintained in their respective limbs until late in development. One of the only other genes known to be expressed specifically in one set of limbs from such an early stage is Pitx1, which is expressed only in the hindlimbs (62, 92) , and which has been shown to cooperatively interact with another T-box gene, Tbx19, in the pituitary (see below). Thus, it was widely hypothesized that Tbx4 and Tbx5 conferred hindlimb and forelimb identities, possibly in cooperation with Pitx1. Ectopic expression studies in chick reinforced this hypothesis. Electroporation of Tbx4 into the forelimb or Tbx5 into the hindlimb produced a variety of malformations, some of which suggested transformation to opposing limb fates (88, 105) . However, these experiments were complicated by the presence of the endogenous T-box gene activity. Electroporation of Tbx4 or Tbx5 into the limb where each is normally expressed also created severe abnormalities, further confounding analysis and again demonstrating the dosage sensitivity characteristic of this gene family.
Mutations in both Tbx4 and Tbx5 are associated with dominant limb defect syndromes in humans: Heterozygous mutations in TBX4 cause small patella syndrome, characterized by minor hip, knee, and foot defects (10); heterozygous mutations in TBX5 cause HOS, characterized by moderate-to-severe arm defects in addition to heart abnormalities (7). Targeted mutations in mouse have shown that Tbx4 and Tbx5 play similar, but not identical, roles in limb outgrowth. In Tbx5 homozygous mutants, the forelimb field is defined and appropriate anterior/posterior and dorsoventral patterning is established (1). However, Fgf10, a gene critical for bud formation and outgrowth, is not expressed in the forelimb bud mesenchyme and a morphological bud is never observed. In Tbx4 homozygous mutants, limb bud formation progresses somewhat further (72) . The hindlimb bud of Tbx4 mutant embryos is morphologically evident and mesenchymal and ectodermal FGF signaling is initiated. Fgf10 is rapidly lost in the mesenchyme, however, and the limb does not progress beyond the bud stage. The mechanism behind the differences between Tbx4 and Tbx5 is not known.
The failure of limb outgrowth prevented assessment of forelimb/hindlimb identity in the Tbx4 and Tbx5 null embryos. A recent study using a conditional Tbx5 allele in combination with limb-specific recombinase transgenes has definitively negated the role of these genes in determining limb identity (70) . Tbx4 misexpressed in the forelimb field is capable of rescuing Tbx5 homozygous mutant forelimb outgrowth, demonstrating functional overlap between these two genes. However, the Tbx4-rescued limbs are forelimblike and show no morphological or molecular hindlimb characteristics. Conversely, misexpression of Pitx1 with either Tbx4 or Tbx5 in the forelimb induces hindlimb-like morphology, indicating that Pitx1 is indeed a regulator of fore-versus hindlimb identity, whereas Tbx4 and Tbx5 are not.
Tbx2 subfamily members Tbx2 and Tbx3 are also expressed in the developing limb in largely overlapping domains along the anterior and posterior margins of the limb mesenchyme (37, 38). In chick, Tbx2 is restricted slightly more posteriorly than Tbx3 in the posterior limb margin, and is also expressed in the apical ectodermal ridge (AER) at the distal limb margin. Overexpression and dominant negative studies in chick have shown that both Tbx2 and Tbx3 induce posterior digit identities, with Tbx2 having the stronger posteriorizing activity (101) . In the mouse and human, both the expression patterns and roles of Tbx2 and Tbx3 appear to be reversed relative to chick. In mouse, Tbx3 is more restricted in the posterior margin and is expressed in the AER, while Tbx2 is not in the AER (37). In contrast to the chick studies, genetic nulls of each gene in mouse indicate that Tbx3 is required for development of the posterior margin of the limb (28), while Tbx2 has only minor effects (43). In humans, TBX3 is associated with ulnamammary syndrome (5), which causes defects in posterior limb formation, but no mutations have been identified for TBX2.
In addition to the Tbx2 subfamily genes, Tbx15, a member of the Tbx1 subfamily, is also expressed in limb mesenchyme in a pattern complementary to the expression domains of Tbx2 and Tbx3 (3, 96) . Mice mutant for Tbx15 are viable but have widespread minor defects in the skeletal elements of the AER: apical ectodermal ridge limbs, characterized by abnormally short and thin bones with poor articulation. These defects may be caused by diminished proliferation in the early limb bud resulting in smaller precartilaginous mesenchymal condensations. Proliferation is reduced only in the core limb mesenchyme, where Tbx15 is expressed, but is normal in the limb margins, suggesting that Tbx2 and/or Tbx3 may maintain proliferation levels in the latter tissues (see sidebar).
Multiple Craniofacial Effects
TBX1 has been identified as a major gene underlying DiGeorge or del22q11.2 syndrome in humans, a syndrome characterized by craniofacial and cardiovascular defects and heterozygous multigene deletions on chromosome 22 [reviewed in (4) ]. In addition to cardiovascular defects, mice lacking Tbx1 exhibit multiple craniofacial defects similar to DiGeorge patients, including defects in ear and mandible development, cleft palate, and defects in branchiomeric muscles (52, 55, 109). Mutations in the zebrafish homologue reveal that the role of Tbx1 in craniofacial and pharyngeal development (82) is evolutionarily conserved.
Craniofacial development involves complex interactions between ectoderm, anterior mesoderm, endoderm, and neural crestderived mesenchyme. Tbx1 is expressed in both pharyngeal endoderm and anterior mesoderm (23) and has been shown to regulate growth factor expression in the pharyngeal region, providing an explanation for the hypoplasia of pharyngeal mesodermal derivatives in mutants (50, 110, 116) . Potential targets of Tbx1 in the pharyngeal region include Fgf8, Fgf10, and the forkhead transcription factor Foxa2, which in combination with Shh also acts upstream of Tbx1, mediating an autoregulatory loop (50, 110, 116, 118) . Because Tbx1 is expressed in anterior mesoderm rather than neural crest-derived mesenchyme, craniofacial defects affecting bone development observed in Tbx1 homozygous mutant mice,
T-BOX GENES AND CANCER
Mounting evidence indicates a functional link between Tbox genes, cellular proliferation/survival, and tumorigenesis, particularly breast tumors. A direct causal link between Tbox genes and cancer, however, has yet to be unequivocally proven. TBX2 is located within a human chromosomal segment, 17q22-24, which is frequently amplified in breast and pancreatic cancers (6, 51, 67) . Several oncogenic candidates have been identified within this segment, including TBX2, which are frequently overexpressed in a subset of primary tumors and cancer cell lines (6, 51, 67) . Unlike many of the other 17q22-24 candidates, TBX2 is also amplified and overexpressed in a large fraction of BRCA1-and BRCA2-related breast tumors (95) . TBX2 and TBX3 have been molecularly linked to the cell cycle machinery via the ARF-MDM2-p53 pathway. TBX2 and TBX3 can rescue a premature senescence phenotype in murine embryonic fibroblasts (20, 51) . Recent work in melanoma cell lines has shown that a dominant negative Tbx2 is able to induce senescence (108) . Both genes can also bind a putative TBE in the human p14 ARF promoter and TBX2 can repress a p14 ARF expression reporter in vitro (65) . TBX2 is capable of repressing other transcripts from the Cdkn gene family, including p15
INK4b , p16 INK4a (51), and p21 (83). There is no evidence, however, of p15
INK4b , p16 INK4a , ARF, or p21 overexpression in Tbx2 homozygous null mutant embryos, and no evidence of a genetic interaction between Tbx2 (or Tbx3) and p53 (43, 53). Nonetheless, the impaired proliferation of the mammary gland ductal tree in Tbx3 heterozygous mice and the exacerbation of this phenotype in double heterozygous Tbx2; Tbx3 mice (53) demonstrate the important contribution of these genes to normal mammary development and suggest that further work is required to determine how misregulation of TBX2 or TBX3 can contribute to mammary tumorigenesis. such as micrognathia (small mandible), may be secondary to failure of mesodermal specification and/or mesodermal or endodermalderived signaling to surrounding cell types.
Overexpression of human TBX1 and three adjacent genes in transgenic mice leads to a spectrum of craniofacial and pharyngeal defects that overlaps with the Tbx1 null phenotype (34). Dosage compensation using a Tbx1 null allele reveals that the majority of defects, including cleft palate, thymic hypoplasia, and cardiovascular defects, are due specifically to overexpression of Tbx1, suggesting that closely regulated levels of Tbx1 are required for normal development and that either too much or too little can incur similar phenotypic defects (63) (see sidebar). However, inner ear defects and hearing loss observed in mice overexpressing Tbx1 are not complemented by Tbx1 null alleles, suggesting a different mechanism of Tbx1 action in the otic epithelium. Tbx1 specifies regional identity and fate boundary formation in the otic epithelium at early stages of inner ear development and acts cell autonomously to expand a population of cells that normally give rise to vestibular and auditory organs (86, 111) . Overexpression of Tbx1 leads to ectopic inner ear sensory organs, whereas loss leads to failure of sensory organ development and expanded neurogenesis. Tbx1 therefore operates as a selector gene in the otocyst, controlling sensory versus neural cell fate (86) .
Tbx1 also plays a central role in craniofacial muscle development. Branchiomeric skeletal muscles are derived from the mesodermal core of the pharyngeal arches. The most anterior, or mandibular, pharyngeal arch forms normally in the absence of Tbx1 (52, 55, 109); however, the myogenic determination genes Myf5 and MyoD fail to be activated, resulting in defects in jaw muscles (55). Tbx1 regulates, but is not absolutely required for, myogenic specification in the mandibular arch since a low level of myogenic determination gene activation occurs sporadically in the absence of Tbx1, producing severely hypoplastic or unilateral jaw muscles. Tbx1 therefore confers robustness on myogenic specification in the mandibular arch.
Another T-box gene, TBX22, is also required for palate development and mutations cause X-linked cleft palate and ankyloglossia (11, 69) . The expression pattern of murine Tbx22 is consistent with a role in the nasal septum during palatal shelf fusion, and in the tissue bridge between the tongue and floor of the mouth (44). It is not known whether Tbx22 interacts epistatically with Tbx1 during palate development.
Cell Fate in the Pituitary
Tbx19 (119) , also known as Tpit, is expressed in the two pro-opiomelanocortin (POMC)-expressing lineages of the pituitary gland, the adrenocorticotrophic hormone (ACTH) producing corticotrophs of the anterior lobe and the melanotrophs of the intermediate lobe.
Loss-of-function mutations in human TBX19 cause early onset ACTH deficiency. These mutations appear to be completely recessive as heterozygous humans and mice have no ACTH deficiency and heterozygous mice have normal numbers of POMC-expressing cells in their pituitaries (84, 85) . Tbx19 expression initiates prior to POMC expression during embryonic development and is also present in the adult pituitary. Although not required for lineage commitment of POMCexpressing cells, Tbx19 is required for the terminal differentiation of corticotrophs and melanotrophs and for successful upregulation of POMC. Tbx19 also represses gonadotroph differentiation, leading to the idea that this factor is responsible for alternative cell fates during pituitary development (61, 66, 85) . Tbx19 activates POMC transcription in cooperation with Pitx1 (61, 66) through the recruitment of SRC/p160 coactivators to its cognate DNA target, the Tpit/Pitx regulatory element in the POMC promoter. This recruitment is mediated by direct binding between Tpit and SRC-2 and is upregulated by mitogen-activated protein kinase activity (68).
T-Box Genes in T Cells
Two T-box genes of the Tbr1 subfamily, Eomesodermin and Tbx21 (also known as T-bet for T-box expressed in T cells), are important in the differentiation of both T and B cells of the immune system [reviewed by (39, 103) ]. Adult mice with a null mutation in Tbx21 show a complete lack of the T helper cell subset Th1, as well as effects on B cells and natural killer cells (39, 103, 104) . Homozygous Eomesodermin mutants die in early gestation (see section on extraembryonic tissues), but heterozygous mutants display defects in CD8 + T cells. There are indications that Eomesodermin and Tbx21 work cooperatively in governing cellular immunity (79) .
Tbx21 has a critical role in initiating Th1 development from naïve precursors both by inducing the Th1 terminal differentiation pathway and also by repressing the alternative Th2 differentiation pathway. Although it is not entirely clear how this effect is mediated, it very likely involves regulation of the interferon-γ locus, a definitive hallmark of the Th1 lineage, and may also involve chromatin remodeling (103) . Because of this pivotal role in the differentiation of lymphoid cells, Tbx21 is an important player in immune responses to infection and in autoimmune disease processes. For example, it has key roles in the pathogenesis of lupus (80), T-cell mediated colitis and Crohn's disease (73) , and metastasis of primary prostate cancer (81) . There is an association between type 1 diabetes and Tbx21 polymorphisms in humans (54, 91). Mice with a null mutation in Tbx21 show airway inflammatory features characteristic of asthma, whereas human asthma patients have reduced TBX21 expression (32).
SUMMARY POINTS
1. The T-box gene family, present in all metazoans, consists of 17 genes in mammals organized into 5 subfamilies.
2. T-box genes are expressed throughout development in dynamic patterns with both unique and overlapping areas of expression.
POMC: proopiomelanocortin
ACTH: adrenocorticotrophic hormone
www.annualreviews.org • T-Box Genes in Development3. T-box proteins bind a common element, the T-site or TBE, but promoter specificity is provided by interactions with other transcription factors and different binding kinetics.
4. Mutations in T-box genes are responsible for developmental defects in many organisms, including several dominant or semidominant human developmental syndromes.
5. Dosage sensitivity to T-box proteins is frequently observed, with too much protein as disruptive as too little.
6. T-box factors function in a wide range of signaling pathways, but common themes put T-box genes downstream of BMP signaling and upstream of FGF signaling.
FUTURE DIRECTIONS
In vitro data have shown interactions between T-box proteins and other transcription factors in cooperative binding experiments. T-box proteins also have the potential to heterodimerize and are often expressed in overlapping patterns. A challenge for the future is to investigate the in vivo relevance of these interactions.
Little is known about how the complex expression profiles of T-box genes or the tightly regulated protein levels are achieved.
Because of the complex expression patterns of T-box genes, mutational analysis has not yet addressed all the possible developmental roles, and because early lethality often limits the exploration of later stages, new alleles, including conditional and hypomorphic alleles, will be needed.
While some developmental requirements for T-box genes have been demonstrated, relatively few downstream target genes effecting these functions have been identified.
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